Gemcitabine-induced hemolytic uremic syndrome mimicking scleroderma renal crisis presenting with Raynaud's phenomenon, positive antinuclear antibodies and hypertensive emergency

Internal Medicine

Volumn 53, Issue 5, 2014, Pages 445-448

  Yamada, Yuichiro ^a   Suzuki, Keisuke ^a   Nobata, Hironobu ^a   Kawai, Hirohisa ^a   Wakamatsu, Ryo ^a   Miura, Naoto ^a   Banno, Shogo ^a   Imai, Hirokazu ^a  

^a AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antinuclear antibody; Fresh frozen plasma; Gemcitabine; Hemolytic uremic syndrome; Hypertensive emergency; Raynaud's phenomenon

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTINUCLEAR ANTIBODY; BILIRUBIN; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOPAMINE; FRESH FROZEN PLASMA; GEMCITABINE; GIMERACIL; HAPTOGLOBIN; HEMOGLOBIN; LACTATE DEHYDROGENASE; NORADRENALIN; SODIUM; TEGAFUR; DEOXYCYTIDINE; IMMUNOSUPPRESSIVE AGENT; RIBONUCLEOTIDE REDUCTASE;

ADULT; ARTICLE; CANCER SURGERY; CASE REPORT; CELL PROLIFERATION; COMPUTER ASSISTED TOMOGRAPHY; CRACKLE; ECHOCARDIOGRAPHY; ERYTHROCYTE COUNT; FEMALE; FIBROSING ALVEOLITIS; GALLBLADDER CANCER; GLOMERULOSCLEROSIS; HAND PAIN; HEMANGIOMA; HEMATOCRIT; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN TISSUE; KIDNEY DYSFUNCTION; LEG EDEMA; MALIGNANT HYPERTENSION; MIDDLE AGED; OCCULT BLOOD; PLEURA EFFUSION; PROTEINURIA; RAYNAUD PHENOMENON; SWELLING; THORAX RADIOGRAPHY; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; VASCULAR LESION; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; BLOOD; BLOOD PRESSURE; CHEMICALLY INDUCED; DIFFERENTIAL DIAGNOSIS; EMERGENCY; GALLBLADDER NEOPLASMS; GLOMERULUS; HEMOLYTIC-UREMIC SYNDROME; HYPERTENSION, MALIGNANT; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RAYNAUD DISEASE; SCLERODERMA, SYSTEMIC;

ANTIBODIES, ANTINUCLEAR; BLOOD PRESSURE; DEOXYCYTIDINE; DIAGNOSIS, DIFFERENTIAL; EMERGENCIES; FEMALE; GALLBLADDER NEOPLASMS; HEMOLYTIC-UREMIC SYNDROME; HUMANS; HYPERTENSION, MALIGNANT; IMMUNOSUPPRESSIVE AGENTS; KIDNEY GLOMERULUS; MIDDLE AGED; RAYNAUD DISEASE; RIBONUCLEOTIDE REDUCTASES; SCLERODERMA, SYSTEMIC;

EID: 84895194823     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.53.1160     Document Type: Article

References (22)

1. Carmichael J. The role of gemcitabine in the treatment of other tumours. Br J Cancer 78: 21-25, 1998.
2. Moore MJ, Tannock IF, Ernst DS, Huan S, Murray N. Gemcitabine: a promising new agent in the treatment of advanced urothelial cancer. J Clin Oncol 15: 3441-3445, 1977.
3. Sternberg CN. Gemcitabine in bladder cancer. Semin Oncol 27: 31-39, 2000.
4. Brodowicz T, Breiteneder S, Wiltschke C, Zielinski CC. Gemcitabine-induced hemolytic uremic syndrome: a case report. J Natl Cancer Inst 89: 1895-1896, 1997.
5. Choi M, Woywodt A, Gobel U, Schneider W, Kettritz R. Haemolytic uraemic syndrome after gemcitabine treatment for pancreatic carcinoma. Nephrol Dial Transplant 14: 2523-2524, 1999.
6. Fung MC, Storniolo AM, Nguyen B, Arning M, Brookfield W, Vigil J. A review of hemolytic uremic syndrome in patients treated with gemcitabine therapy. Cancer 85: 2023-2032, 1999.
7. Walter RB, Joerger M, Pestalozzi BC. Gemcitabine-associated hemolytic-uremic syndrome. Am J Kidney Dis 40: E16, 2002.
8. Muller S, Schutt P, Bojko P, et al. Hemolytic uremic syndrome following prolonged gemcitabine therapy: report of four cases from a single institution. Ann Hematol 84: 110-114, 2005.
9. Humphreys BD, Sharman JP, Henderson JM, et al. Gemcitabineassociated thrombotic microangiopathy. Cancer 100: 2664-2670, 2004.
10. Saif MW, McGee PJ. Hemolytic-uremic syndrome associated with gemcitabine: a case report and review of literature. JOP 6: 369-374, 2005.
11. Izzedine H, Isnard-Bagnis C, Launay-Vacher V, et al. Gemcitabine-induced thrombotic microangiopathy: a systematic review. Nephrol Dial Transplant 21: 3038-3045, 2006.
12. Kalra N, Kad R, Osama S. Gemcitabine-induced hemolytic uremic syndrome in ovarian carcinoma. Int J Clin Oncol 12: 385-387, 2007.
13. Boeck S, Geiger S, Schulz C, Heinemann V. Hemolytic-uremic syndrome associated with gemcitabine treatment for metastatic pancreatic cancer. J Clin Gastroenterol 42: 551-552, 2008.
14. Gore EM, Jones BS, Marques MB. Is therapeutic plasma exchange indicated for patients with gemcitabine-induced hemolytic uremic syndrome? J Clin Apher 24: 209-214, 2009.
15. Moake JL. Thrombotic microangiopathies. N Engl J Med 347: 589-600, 2002.
16. Blake-Haskins JA, Lechleider RJ, Kreitman RJ. Thrombotic microangiopathy with targeted cancer agents. Clin Cancer Res 17: 5858-5866, 2011.
17. Clowse MEB, Wigley FM. Digital necrosis related to carboplatin and gemcitabine therapy in systemic sclerosis. J Rheumatol 30: 1341-1343, 2003.
18. Marie I, Levesque H, Plissonnier D, Balguerie X, Cailleux N, Courtois H. Digital necrosis related to cisplatin in systemic sclerosis. Br J Dermatol 142: 833-834, 2000.
19. Zaima C, Kanai M, Ishikawa S, et al. A case of progressive digital ischemia after early withdrawal of gemcitabine and S-1 in a patient with systemic sclerosis. Jpn J Clin Oncol 41: 803-806, 2011.
20. Bessis D, Guillot B, Legouffe E, Guilhou JJ. Gemcitabineassociated scleroderma-like changes of the lower extremities. J Am Acad Dermatol 51 (2 Suppl): S73-S76, 2004.
21. Zemtsov A, Omueti-Ayoade K, Zemtsov R, Yang M. Livedo reticularis as an initial clinical manifestation of gemcitabine-induced hemolytic uremic syndrome. J Dermatol 39: 487-489, 2012.
22. Mir-Bonafe JM, Roman-Curto C, Santos-Briz A, Canueto J, Fernandez-Lopez E, Unamuno P. Gemcitabine-associated livedoid thrombotic microangiopathy with associated sclerema neonatorumlike microscopic changes. J Cutan Pathol 39: 707-711, 2012.